101823892_antony
liked and commented on
$GRI Bio (GRI.US)$ GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
1 MINUTE AGO, 8:45 AM EST
VIA GLOBENEWSWIRE
Workshop, poster and oral presentation of data given as part of the 8th Annual Antifibrotic Drug Development (AFDD) Summit
Data demonstrate that NKT cells are activated in airways in IPF patients and inhibition of iNKT cell activity with GRI-0621 ameliorates pulmonary fibrosis in a pr...
1 MINUTE AGO, 8:45 AM EST
VIA GLOBENEWSWIRE
Workshop, poster and oral presentation of data given as part of the 8th Annual Antifibrotic Drug Development (AFDD) Summit
Data demonstrate that NKT cells are activated in airways in IPF patients and inhibition of iNKT cell activity with GRI-0621 ameliorates pulmonary fibrosis in a pr...
3
3
101823892_antony
liked and commented on
$GRI Bio (GRI.US)$
GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
GRI Bio presented positive preclinical data for GRI-0621, its lead program targeting Idiopathic Pulmonary Fibrosis (IPF), at the 8th Annual Antifibrotic Drug Development Summit. The data showed that GRI-0621 reduces inflammation and fibrotic drivers in IPF. Key findings demonstrated increased iNKT cell activity correlating with f...
GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
GRI Bio presented positive preclinical data for GRI-0621, its lead program targeting Idiopathic Pulmonary Fibrosis (IPF), at the 8th Annual Antifibrotic Drug Development Summit. The data showed that GRI-0621 reduces inflammation and fibrotic drivers in IPF. Key findings demonstrated increased iNKT cell activity correlating with f...
2
1
101823892_antony
voted
Happy weekend, investors! Welcome back to Weekly Buzz where we talk about the top ten buzzing stocks on moomoo this week! Comment below to answer the Weekly Topic question for a chance to win an award!
Make Your Choice
Weekly Buzz
This week was the first full trading week after the presidential election, and the market continued to respond positively to President-Elect Donald Trump and watched as the GOP won a majority in the Congressional House and Senat...
Make Your Choice
Weekly Buzz
This week was the first full trading week after the presidential election, and the market continued to respond positively to President-Elect Donald Trump and watched as the GOP won a majority in the Congressional House and Senat...
+10
80
42
$GRI Bio (GRI.US)$ Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis
101823892_antony
commented on
$Clover Health (CLOV.US)$ Clover Health Reports Strong Financial Growth in Q3 2024
1
2
101823892_antony
reacted to
$VivoPower (VVPR.US)$ VivoPower's Tembo announces definitive agreement with pre-eminent jeepney group, Sarao Motors, in the Philippines' estimated US$10bn jeepney market
4
$Clover Health (CLOV.US)$ will go up since Trump win for next few days for all USA companies
1
101823892_antony
commented on
$Palantir (PLTR.US)$ posted accelerating quarterly growth on Monday afternoon, again fueled by artificial intelligence.
Roughly 150% stock rally so far in 2024 shows that investors have given the enterprise software company respect for its own AI initiatives.
.
$Palantir (PLTR.US)$ Climbed 8% 📈 the highest on the S&P 500, after news it would move its class A shares from the New York Stock Exc...
Roughly 150% stock rally so far in 2024 shows that investors have given the enterprise software company respect for its own AI initiatives.
.
$Palantir (PLTR.US)$ Climbed 8% 📈 the highest on the S&P 500, after news it would move its class A shares from the New York Stock Exc...
+18
84
22
$Palantir (PLTR.US)$ I selling my 50k share,bye
2
3
101823892_antony : will it move to 1.1